Slow Capital, Inc. Gilead Sciences, Inc. Transaction History

Slow Capital, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $273,845 - $343,158	-4,728 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $9,472 - $10,751	-146 Reduced 3.0%	4,728 $343,000
Q3 2021 Oct 21, 2021	BUY	$67.69 - $73.03 $20,171 - $21,762	298 Added 6.51%	4,874 $340,000
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $12,694 - $13,869	200 Added 4.57%	4,576 $315,000
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $42,360 - $48,332	706 Added 19.24%	4,376 $283,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $34,953 - $39,827	617 Added 20.21%	3,670 $214,000
Q3 2020 Nov 04, 2020	BUY	$62.1 - $78.08 $189,591 - $238,378	3,053 New	3,053 $193,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $38,928 - $45,408	-600 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $42,690 - $50,112	600	600 $43,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Slow Capital, Inc. with notifications on news.